Boston Scientific (BSX) stock Forecast for 2022 – 2026
Last update: November 27, 2022 (09:47)Sector: Healthcare
The share price of Boston Scientific Corp. (BSX) now
What analysts predict: $48.92
52-week high/low: $47.5 / $34.98
50/200 Day Moving Average: $41.15 / $41.18
This figure corresponds to the average price over the previous 50/200 days. For Boston Scientific stocks, the 50-day moving average is the support level today.
For Boston Scientific stocks, the 200-day moving average is the support level today.
Are you interested in Boston Scientific Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Boston Scientific stock price in 2022, 2023, 2024, 2025, 2026. How much will one Boston Scientific share be worth in 2022 - 2026?
When should I take profit in Boston Scientific stock? When should I record a loss on Boston Scientific stock? What are analysts' forecasts for Boston Scientific stock? What is the future of Boston Scientific stock? We forecast Boston Scientific stock performance using neural networks based on historical data on Boston Scientific stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Boston Scientific stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Boston Scientific shares. This happens once a day.
Historical and forecast chart of Boston Scientific stock
The chart below shows the historical price of Boston Scientific stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Boston Scientific stock price can be found in the table below.
Long-term forecasts by years.
Boston Scientific daily forecast for a month
Boston Scientific Daily Price Targets
Boston Scientific Stock Forecast 11-29-2022.
Forecast target price for 11-29-2022: $44.67.
Positive dynamics for Boston Scientific shares will prevail with possible volatility of 1.513%.
Pessimistic target level: 44.19
Optimistic target level: 44.87
Boston Scientific Stock Forecast 11-30-2022.
Forecast target price for 11-30-2022: $44.61.
Negative dynamics for Boston Scientific shares will prevail with possible volatility of 2.233%.
Pessimistic target level: 44.14
Optimistic target level: 45.15
Boston Scientific Stock Forecast 12-01-2022.
Forecast target price for 12-01-2022: $44.14.
Negative dynamics for Boston Scientific shares will prevail with possible volatility of 1.787%.
Pessimistic target level: 43.67
Optimistic target level: 44.46
Boston Scientific Stock Forecast 12-02-2022.
Forecast target price for 12-02-2022: $44.14.
Negative dynamics for Boston Scientific shares will prevail with possible volatility of 2.186%.
Pessimistic target level: 43.45
Optimistic target level: 44.42
Boston Scientific Stock Forecast 12-03-2022.
Forecast target price for 12-03-2022: $43.72.
Negative dynamics for Boston Scientific shares will prevail with possible volatility of 1.667%.
Pessimistic target level: 43.32
Optimistic target level: 44.05
Boston Scientific Stock Forecast 12-04-2022.
Forecast target price for 12-04-2022: $43.86.
Positive dynamics for Boston Scientific shares will prevail with possible volatility of 1.786%.
Pessimistic target level: 43.40
Optimistic target level: 44.19
BSX (BSX) Monthly Stock Prediction for 2022
Boston Scientific forecast for this year
Boston Scientific Stock Prediction for Dec 2022
An uptrend is forecast for this month with an optimal target price of $45.5798. Pessimistic: $44.50. Optimistic: $46.41
Boston Scientific (BSX) Monthly Stock Prediction for 2023
Boston Scientific (BSX) Monthly Stock Prediction for 2024
Boston Scientific (BSX) Monthly Stock Prediction for 2025
Boston Scientific (BSX) Monthly Stock Prediction for 2026
Boston Scientific information and performance
Boston Scientific Corporation is a global creator, manufacturer and marketer of medical devices, their products are used in the interventional fields of medicine including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular interventions, electrophysiology, cardiovascular surgery, vascular surgery, endoscopy, oncology, urology and gynecology. The manufacturer is famous for its Taxus stent, which contains the medication Paclitaxel and is used for clogged arteries.
Boston Scientific was formed in June 1979 under the name Medi-Tech and immediately positioned itself as a company for growth in interventional medicine. In April 2006, the firm acquired its former rival Guidant for $ 27.2 billion, and the former Guidant was split between BSC and Abbott Laboratories. In 2008, another major major firm, MAQUET, takes over the cardiac and vascular surgery department of the Boston Scientific Corporation. American businessman John Abel (director) together with Peter Nicholas (chairman) are the founders of BSC.
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, US
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.